Advancing PKD Research: Be Part of the Breakthrough
PKD research advances better treatments, earlier diagnosis, and the hope of prevention. Studies have improved blood pressure management and led to therapies that can slow disease progression. Ongoing research helps scientists better understand how cysts grow and develop new medications to protect kidney function.
Taking part in a PKD study is a meaningful way to support this progress. Clinical trials and observational studies provide vital information about how the disease develops and how treatments work in real life. Participants may also benefit from access to new therapies and closer medical monitoring.
Each person who joins a study helps move the field closer to better outcomes and greater hope for future generations.
HIYA-PKD Study
High blood pressure (hypertension) can be an early sign of PKD, even in children.
The HIYA-PKD study is exploring how common high blood pressure is in children and young people at risk of Autosomal Dominant Polycystic Kidney Disease ADPKD).
Researchers are looking for untested 12–17-year-olds who have a parent or sibling with PKD to take part.
The IMPEDE-PKD trial is recruiting in the UK to explore whether metformin, a medication commonly used to treat diabetes, can help slow disease progression in people with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
We welcome feedback on the information provided on this webpage. If you have any feedback regarding the information provided on this webpage, please complete the Feedback Form